Abstract
Background: Various clinical studies have revealed that cardiovascular diseases (CVD) are associated with bone loss diseases such as osteoporosis and periodontitis, especially in older population. As one of the best-established risk factors of CVD, hyperlipidemia is also reported to interfere with the metabolism, function and regeneration of mineralized tissues. Derived from postnatal tissue reservoirs, mesenchymal stem cells (MSCs) are considered promising cell sources for mesenchymal and non-mesenchymal tissue regeneration based on their capacities for self-renewal and multi-lineage differentiation as well as potent immunosuppressive effects, secretion of cytokines and regulation of vascularization. MSCs could home to the injury sites from peripheral circulation, proliferate and differentiate into bone-forming cells, therefore significantly enhancing bone regeneration. However, elevated blood lipid levels affect the physiological behaviors of MSCs, as well as the performance of transplanted MSCs.
Objective: This review aims to summarize the effects of hyperlipidemia and CVD on the proliferation, osteogenic differentiation and homing of MSCs. The principal observations of the underlying cellular and molecular mechanisms as well as the effects of lipid-lowering therapy on MSCs are also discussed.Keywords: Cardiovascular diseases, homing, hyperlipidemia, mesenchymal stem cells, osteogenic differentiation, proliferation.
Current Stem Cell Research & Therapy
Title:Effects of Hyperlipidemia and Cardiovascular Diseases on Proliferation, Differentiation and Homing of Mesenchymal Stem Cells
Volume: 12 Issue: 5
Author(s): Xin Ye and Chengfei Zhang *
Affiliation:
- Comprehensive Dental Care, Faculty of Dentistry, University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR,China
Keywords: Cardiovascular diseases, homing, hyperlipidemia, mesenchymal stem cells, osteogenic differentiation, proliferation.
Abstract: Background: Various clinical studies have revealed that cardiovascular diseases (CVD) are associated with bone loss diseases such as osteoporosis and periodontitis, especially in older population. As one of the best-established risk factors of CVD, hyperlipidemia is also reported to interfere with the metabolism, function and regeneration of mineralized tissues. Derived from postnatal tissue reservoirs, mesenchymal stem cells (MSCs) are considered promising cell sources for mesenchymal and non-mesenchymal tissue regeneration based on their capacities for self-renewal and multi-lineage differentiation as well as potent immunosuppressive effects, secretion of cytokines and regulation of vascularization. MSCs could home to the injury sites from peripheral circulation, proliferate and differentiate into bone-forming cells, therefore significantly enhancing bone regeneration. However, elevated blood lipid levels affect the physiological behaviors of MSCs, as well as the performance of transplanted MSCs.
Objective: This review aims to summarize the effects of hyperlipidemia and CVD on the proliferation, osteogenic differentiation and homing of MSCs. The principal observations of the underlying cellular and molecular mechanisms as well as the effects of lipid-lowering therapy on MSCs are also discussed.Export Options
About this article
Cite this article as:
Ye Xin and Zhang Chengfei*, Effects of Hyperlipidemia and Cardiovascular Diseases on Proliferation, Differentiation and Homing of Mesenchymal Stem Cells, Current Stem Cell Research & Therapy 2017; 12 (5) . https://dx.doi.org/10.2174/1574888X12666170316105805
DOI https://dx.doi.org/10.2174/1574888X12666170316105805 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 3
Current Drug Delivery Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells
Current Pharmaceutical Biotechnology Electron Spin Resonance as a Powerful Tool for Studying Antioxidants and Radicals
Current Medicinal Chemistry Biomaterials and Scaffolds in Bone and Musculoskeletal Engineering
Current Stem Cell Research & Therapy Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response
Current Pharmaceutical Design “Potential natural antioxidants: adjuvant effect of green tea polyphenols in periodontal infections”
Infectious Disorders - Drug Targets New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Patients with Hereditary Hemorrhagic Telangectasia (HHT) Exhibit a Deficit of Polymorphonuclear Cell and Monocyte Oxidative Burst and Phagocytosis: A Possible Correlation with Altered Adaptive Immune Responsiveness in HHT
Current Pharmaceutical Design Oral Colonization by Nosocomial Pathogens During Hospitalization in Intensive Care Unit and Prevention Strategies
Recent Patents on Anti-Infective Drug Discovery Delivery and Application of Dietary Polyphenols to Target Organs, Tissues and Intracellular Organelles
Current Drug Metabolism The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP Inhibitors
Current Topics in Medicinal Chemistry Impact of Different Implant Surfaces Topographies on Peri-Implant Tissues: An Update of Current Available Data on Dental Implants Retrieved from Human Jaws
Current Pharmaceutical Biotechnology Cigarette Smoke Exposure Inhibits Early Phase of Antibody Production through Inhibition of Immune Functions in Alveolar Macrophage
Current Respiratory Medicine Reviews Biomarkers for Radiographic Progression in Rheumatoid Arthritis
Current Pharmaceutical Design Glycosylation of the Arg-gingipains of Porphyromonas gingivalis and Comparison with Glycoconjugate Structure and Synthesis in other Bacteria
Current Protein & Peptide Science Growth Factor Delivery to Re-Engineer Periodontal Tissues
Current Pharmaceutical Biotechnology Flavonoids Protect Cerebrovascular Endothelial Cells through Nrf2 and PI3K from β-Amyloid Peptide-Induced Oxidative Damage
Current Neurovascular Research